1Koshikawa N,Hasegawa S,Nagashima Y,et al.Expression of trypsin by epithelial cells of various tissues, leukocytes, and neurons in human and mouse [J].Am J Pathol, 1998,153 (3):937-944.
2Shimamoto R,Sawada T,Uchima Y,et al.A role for pro- tease-activated receptor-2 in pancreatic cancer cell prolife- ration[J].Int J Oncol, 2004,24(6): 1401-1406.
3Yamamoto H,Iku S,Adachi Y,et al. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer [J].J Pathol, 2003,199(2): 176-184.
4Li Z,Bian LJ,Li Y,et al.Expression of protease-activated receptor-2 (PAR-2)in patients with nasopharyngeal carci- noma:correlation with clinicopathological features and prognosis[J].Pathol Res Pract, 2009,205 (8):542-550.
5Hedstrom J, Haglund C, Leinonen J, et al .Trypsinogen-1, - 2 and tumour-associated trypsin-inhibitor in bile and bi- liary tract tissues from patients with biliary tract diseases and pancreatic carcinomas [J].Scand J Clin Lab Invest, 2001,61(2):111-118.
10Jiang R,Zatta A,Kin H,ct al. PAR-2 activation at the time of reperfusion salvages myocardium via an ERK1/2 pathway in invivo rat hearts [J].Am J Physiol Heart Circ Physiol, 2007,293(5):H2845-2852.
3Attar RM,Takimoto CH,Gottardis MM.Castration-resistant prostate cancer:locking up the molecular escape routes.Clinical Cancer Research,2009,15 (10):3251-3255.
4Debes JD,Tindall DJ.Mechanisms of androgen-refractory prostate cancer.New England Journal of Medicine,2004,351 (15):1488-1490.
5Visakorpi T,Hyytinen E,Koivisto P,et al.In vivo amplification of the androgen receptor gene and progression of human prostate cancer.Nature genetics,1995,9(4):401-406.
7Kaushal V,Kohli M,Dennis RA,et al.Thrombin receptor expression is upregulated in prostate cancer.The Prostate,2005,66(3):273-282.
8Jiang R,Zatta A,Kin H,et al.PAR-2 activation at the time of reperfusion salvages myocardium via an ERK1/2 pathway in in vivo rat hearts.American Journal of Physiology-Heart and Circulatory Physiology,2007,293 (5):H2845-H2852.
9Borensztajn KS,Spek CA.Protease-activated receptors,apoptosis and tumor growth.Pathophysiology of Haemostasis and Thrombosis,2007,36(3-4):137-147.
10Tracey L,Pérez-Rosado A,Artiga MJ,et al.Expression of the NF-κB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas,respectively.The Journal of pathology,2005,206(2):123-134.
